Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

P. Shah, Neil; Bhatia, Ravi; K. Altman, Jessica; L. Amaya, Maria; H. Begna, Kebede; Berman, Ellin; Chan, Onyee; Clements, Joan; H. Collins, Robert; Curtin, Peter; J. DeAngelo, Daniel; W. Drazer, Michael; J. Maness, Lori; Metheny, Leland; Mohan, Sanjay; O. Moore, Joseph; G. Oehler, Vivian; W. Pratz, Keith; Pusic, Iskra; G. Rose, Michal; Shomali, William; Douglas Smith, B.; Styler, Michael; Talpaz, Moshe; Tanaka, Tiffany; K. Tantravahi, Srinivas; E. Thompson, James; Tsai, Steven; E. Vaughn, Jennifer; Welborn, Jeanna; T. Yang, David; Sundar, Hema; M. Gregory, Kristina

doi:10.6004/jnccn.2024.0007

Public

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Feb 1, 2024

Authors:

Neil P. Shah

Ravi Bhatia

Jessica K. Altman

Abstract

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome resulting from a reciprocal translocation between chromosomes 9 and 22 [t9;22] that gives rise to a BCR::ABL1 fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diag...

Subject

Medicine

Discontinuation

Myeloid leukemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!